ACMI
BIIB icon

Amida Capital Management II’s Biogen BIIB Stock Holding History

Amida Capital Management II’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-200
Closed -$48K – 78
2013
Q3 		$48K Hold
200
– – 0.02% 111
2013
Q2 		$43K Buy
+200
New +$42.7K 0.01% 207

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Amida Capital Management II's BIIB Position: Q4 2013 in Review

Amida Capital Management II sold out of Biogen (BIIB) in Q4 2013, closing a stake of 200 shares — an estimated $48K sold.

Amida Capital Management II first reported a position in BIIB in Q2 2013 and held it in 2 quarters. The position peaked at $48K in Q3 2013. 739 funds tracked by Wall St. Rank hold BIIB as of Q4 2013.

  • Amida Capital Management II reported no remaining Biogen position as of Q4 2013 after selling out during the quarter.
  • Amida Capital Management II sold 200 Biogen shares in Q4 2013, an estimated $48K.
  • Amida Capital Management II first reported a position in Biogen in Q2 2013 and held it in 2 quarters.
  • Amida Capital Management II's Biogen position peaked at $48K in Q3 2013.
  • 739 funds tracked by Wall St. Rank held Biogen as of Q4 2013.

Based on Amida Capital Management II's 13F filing for Q4 2013, filed 14 Feb 2014.